[go: up one dir, main page]

AU1072195A - Diagnosis of alzheimer's disease - Google Patents

Diagnosis of alzheimer's disease

Info

Publication number
AU1072195A
AU1072195A AU10721/95A AU1072195A AU1072195A AU 1072195 A AU1072195 A AU 1072195A AU 10721/95 A AU10721/95 A AU 10721/95A AU 1072195 A AU1072195 A AU 1072195A AU 1072195 A AU1072195 A AU 1072195A
Authority
AU
Australia
Prior art keywords
alzheimer
diagnosis
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10721/95A
Inventor
Philip Nigel Hawkins
Mark Brian Pepys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royal Postgraduate Medical School
Original Assignee
Royal Postgraduate Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Postgraduate Medical School filed Critical Royal Postgraduate Medical School
Publication of AU1072195A publication Critical patent/AU1072195A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU10721/95A 1993-11-19 1994-11-21 Diagnosis of alzheimer's disease Abandoned AU1072195A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939323826A GB9323826D0 (en) 1993-11-19 1993-11-19 Diagnosis of alzheimer's disease
GB9323826 1993-11-19
PCT/GB1994/002559 WO1995014234A1 (en) 1993-11-19 1994-11-21 Diagnosis of alzheimer's disease

Publications (1)

Publication Number Publication Date
AU1072195A true AU1072195A (en) 1995-06-06

Family

ID=10745393

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10721/95A Abandoned AU1072195A (en) 1993-11-19 1994-11-21 Diagnosis of alzheimer's disease

Country Status (4)

Country Link
EP (1) EP0729581A1 (en)
AU (1) AU1072195A (en)
GB (1) GB9323826D0 (en)
WO (1) WO1995014234A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2969153B1 (en) 2010-12-17 2014-10-17 Lab Francais Du Fractionnement PROCESS FOR THE PURIFICATION OF AMYLOID P PROTEIN AND USE OF THE PROTEIN THUS PURIFIED
WO2020038773A1 (en) 2018-08-21 2020-02-27 Koninklijke Philips N.V. Method and apparatus for amyloid screening

Also Published As

Publication number Publication date
WO1995014234A1 (en) 1995-05-26
EP0729581A1 (en) 1996-09-04
GB9323826D0 (en) 1994-01-05

Similar Documents

Publication Publication Date Title
AU2414092A (en) Diagnostic method for alzheimer's disease
ZA9410095B (en) Methods of inhibiting Alzheimer's Disease
AU5508798A (en) Diagnostic and therapeutic reagents for alzheimer's disease
GB9316727D0 (en) Models of alzheimers's disease
IL105216A0 (en) Method and kit for the diagnosis of alzheimer's disease
AU8392291A (en) Tachykinin agonists for treatment of alzheimer's disease
AU7397094A (en) Prevention and treatment of alzheimer's disease
AU1407399A (en) Treatment for alzheimer's disease
AU7556994A (en) Methods for the diagnosis of alzheimer's disease
HU9302551D0 (en) Compounds having effect against hypoglycemia and alzheimer's disease
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
EP0773797A4 (en) A method of diagnosing alzheimer's disease
AU4759390A (en) Method of medical treatment of alzheimer's disease
AU5857296A (en) Use of leukotriene antagonists for alzheimer's disease
AU1189395A (en) Apolipoprotein e polymorphism and alzheimer's disease
AU4636993A (en) Diagnosing alzheimer's disease and schizophrenia
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
AU1405899A (en) Treatment for alzheimer's disease
AU4012795A (en) Alzheimer's peptide
AU8185491A (en) Treatment of disease
AU1072195A (en) Diagnosis of alzheimer's disease
AU7201696A (en) Method of diagnosing crohn's disease
AU1807592A (en) New combination preparation for treatment of parkinson's disease
AU2990692A (en) Diagnostic method for pompe's disease
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease